Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302, NTI 0303, or Other Designated Studies

NCT00226655 is registered in ClinicalTrials.gov with Celtic Pharma Development Services as lead sponsor.

NCT NCT00226655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00226655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302, NTI 0303, or Other Designated Studies
Lead sponsor
Celtic Pharma Development Services
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2005
Completion date
April 30, 2009
Enrollment
112 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

brain edema, brain tumor